Cipla gains on Q4 results

Total income in the Jan-Mar quarter surged from Rs 10,439 crore to Rs 11,511 crore on year-on-year basis

Shares of Mumbai-based drug maker Cipla are trading higher by 3% to Rs 667 on the BSE after the total income posted by the company surged from Rs 10,439 crore to Rs 11,511 crore on year-on-year basis. The domestic sales in the Jan-March quarter in the current fiscal appreciated from Rs 900 crore in the year ago period to Rs 1,086 crore depicting a jump of 21% on the back of increased sales in respiratory, anti-infective, cardiac and gastro-intestinal categories.

Meanwhile, exports of formulations rose 30% to Rs 1,690 crore during the March quarter in the current year.

However, the company reported consolidated net profit of Rs 260 crore for the March quarter as against Rs261 crore for the corresponding period previous year.

The stock opened at Rs 645 and touched a high of Rs 673 on the BSE. At 11.45 AM, A total of 156,430 shares changed hands on the BSE.